Continuous Glucose Monitoring (CGM)
GLP-1 Agonists
The GLP-1 RA shortage is becoming more pressing and in Dorset we currently prescribe 30% more of these agents than other systems in our region. Tackling this shortage in a structured way will not only reduce the impact on patients who continue to need these treatments but will also help meet CCLIP targets for 23/24.
Glucagon-like peptide – 1 agonists (GLP-1)